Jonathan Milner is a UK based entrepreneur, who has made several contributions towards technology businesses, particularly in the healthcare industry. In the year 1998, he founded Abcam after gaining his molecular genetics doctorate from the University of Leicester. Since then, the company has been carrying antibodies, and also antibody related products like equipments and peptides.
While carrying out his postdoctoral research on the newly discovered BRCA2, a breast cancer protein, Jonathan Milner had to slow down his project due to lack of quality antibody reagents. Most of these did not have updated information regarding their usage and limitations. This motivated Milner to create an online service, which could help researchers all around the world to gain access to the needed information.
Abcam is an e-commerce life science company that allows customers to submit their reviews, ratings and feedback on different products online. The 19th March 2008 edition of the Business Weekly had described Abcam as the ‘Amazon of Antibodies’. The company has also been enlisted on London Stock Exchange.